title: The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
abstract: Patients with comorbid hypertension and type 2 diabetes are common, have a greatly increased risk of premature cardiovascular and renal morbidity and mortality, and are likely to increase substantially in number over the next 10-15 years. We suggest the need for more aggressive management strategies for these patients, regardless of their baseline blood pressure, including the early use of combination therapy with blockers of the renin-angiotensin system.
authors.affiliation: Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. lars.ryden@ki.se
authors.forename: Lars
authors.initials: L
authors.lastname: Rydén
authors.forename: Bernard
authors.initials: B
authors.lastname: Waeber
authors.forename: Luis M
authors.initials: LM
authors.lastname: Ruilope
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Mancia
authors.forename: Massimo
authors.initials: M
authors.lastname: Volpe
authors.forename: Heinrich
authors.initials: H
authors.lastname: Holzgreve
authors.forename: Carl Erik
authors.initials: CE
authors.lastname: Mogensen
authors.forename: Stephane
authors.initials: S
authors.lastname: Laurent
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D019468:Disease Management; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012084:Renin-Angiotensin System / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents